Table 2.
Frequencies of Tau immunoreactivity in abdominal skin based on clinico-pathological diagnosis. Frequency of immunoreactivity is based on number of immunoreactive cases / overall number of cases evaluated. Only 3 cases had immunoreactivity and only with HT7.
| Abdominal Skin | NC | PSP | AD/PSP | CBD | AD | AD/CBD |
|---|---|---|---|---|---|---|
| #HT7 positive cases/total (%) | 0/14 (0%) | 0/15 (0%) | 1/8 (13%) | 1/1 (100%) | 1/16 (6%) | 0/1 (0%) |
| Anatomic location of staining, number of cases | ||||||
| Epidermis | 0 | 0 | 0 | 0 | 0 | 0 |
| Dermis | 0 | 0 | 0 | 0 | 0 | 0 |
| Subcutaneous tissue | 0 | 0 | 0 | 0 | 0 | 0 |
| ducts/glands | 0 | 0 | 1 | 1 | 1 | 0 |
| # of T231 positive cases/total (%) | 0/16 (0%) | 0/13 (0%) | 0/6 (0%) | 0/0 (0%) | 0/21 (0%) | 0/1 (0%) |
| # of AT8 positive cases/total (%) | 0/16 (0%) | 0/15 (0%) | 0/8 (0%) | 0/1 (0%) | 0/15 (0%) | 0/1 (0%) |